Research Institute Havelhöhe, Kladower Damm 221, 14089 Berlin, Germany.
Department of Intensive Care and Cardiology, Hospital Gemeinschaftskrankenhaus Havelhoehe, Kladower Damm 221, 14089 Berlin, Germany.
Int J Environ Res Public Health. 2022 Dec 2;19(23):16124. doi: 10.3390/ijerph192316124.
Evidence suggests that Post/Long-COVID (PLC) is associated with a reduced health-related quality of life, however little knowledge exists on the risk factors that contribute to PLC. The objective of this prospective real-world data study was to evaluate factors associated with PLC using national online survey data. Adjusted multivariable regression analyses were performed using the software R. Between 14 April and 15 June 2021, 99 registered individuals reported to have suffered from PLC symptoms and the most common PLC symptoms reported were fatigue, dyspnoea, decreased strength, hyposmia, and memory loss. The odds of individuals suffering from COVID-19-associated anxiety, hyposmia, or heart palpitations developing PLC were eight times (OR 8.28, 95% CI 1.43−47.85, p < 0.01), five times (OR 4.74, 95% CI 1.59−14.12, p < 0.005), or three times (OR 2.62, 95% CI 1.72−3.99, p < 0.01) higher, respectively, than of those who had not experienced these symptoms. Individuals who experienced fatigue while having COVID-19 were seven times more likely to develop PLC fatigue than those who had not (OR 6.52, 95% CI: 4.29−9.91, p < 0.0001). Our findings revealed that 13% of the individuals who had previously suffered from COVID-19 subsequently reported having PLC. Furthermore, COVID-19-associated anxiety, hyposmia, heart palpitations, and fatigue were, among others, significant determinants for the development of PLC symptoms. Hyposmia has not previously been reported as an independent predictive factor for PLC. We suggest closely monitoring patients with COVID-19-induced fatigue, heart palpitations, and anxiety, as these symptoms may be predictors of PLC symptoms, including fatigue.
有证据表明,长新冠(Post/Long-COVID,PLC)与健康相关的生活质量降低有关,但对于导致 PLC 的风险因素知之甚少。本前瞻性真实世界数据研究的目的是使用全国在线调查数据评估与 PLC 相关的因素。使用 R 软件进行了调整后的多变量回归分析。在 2021 年 4 月 14 日至 6 月 15 日期间,99 名已报告患有 PLC 症状的注册个体参与了该研究,报告的最常见 PLC 症状是疲劳、呼吸困难、力量下降、嗅觉减退和记忆力减退。患有 COVID-19 相关焦虑、嗅觉减退或心悸的个体患 PLC 的几率分别是未出现这些症状个体的 8 倍(OR 8.28,95%CI 1.43−47.85,p<0.01)、5 倍(OR 4.74,95%CI 1.59−14.12,p<0.005)或 3 倍(OR 2.62,95%CI 1.72−3.99,p<0.01)。在患有 COVID-19 的同时出现疲劳的个体患 PLC 疲劳的几率是未出现这种症状的个体的 7 倍(OR 6.52,95%CI:4.29−9.91,p<0.0001)。我们的研究结果表明,在先前患有 COVID-19 的个体中,有 13%的个体随后报告出现了 PLC。此外,COVID-19 相关的焦虑、嗅觉减退、心悸和疲劳等是 PLC 症状发展的重要决定因素。嗅觉减退以前并未被报道为 PLC 的独立预测因素。我们建议密切监测患有 COVID-19 引起的疲劳、心悸和焦虑的患者,因为这些症状可能是 PLC 症状(包括疲劳)的预测因素。